Virios Therapeutics, LLC
SEC CIK 1818844 · VIRI · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Thomas John C | Director | filed 2020 - 2026 |
| Whitley Richard James | Director | filed 2020 - 2026 |
| De La Rosa Abel | Director | filed 2020 - 2026 |
| Keefer David R | Director | filed 2020 - 2026 |
| Duncan Gregory Scott | Director · Chief Executive Officer | filed 2020 - 2026 |
| CK Life Sciences Intl (Holdings) Inc | Director | filed 2024 - 2025 |
| Sealbond Ltd | Director | filed 2024 - 2025 |
| Conjoint Inc. | Director | filed 2025 - 2025 |
| Toh Kean Meng Melvin | Director | filed 2024 - 2024 |
| Yu Ying Choi Alan Abel | Director | filed 2024 - 2024 |
| Pridgen William | Director | filed 2020 - 2024 |
| Burch Richard Alan | Director | filed 2020 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Walsh Angela | VP of Finance | filed 2020 - 2026 |
| Grosswald Ralph | Vice President of Operations | filed 2020 - 2026 |
| Gendreau Roger Michael | Chief Medical Officer | filed 2020 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.